S
Susan R. Davis
Researcher at Monash University
Publications - 430
Citations - 24535
Susan R. Davis is an academic researcher from Monash University. The author has contributed to research in topics: Testosterone (patch) & Menopause. The author has an hindex of 76, co-authored 412 publications receiving 21882 citations. Previous affiliations of Susan R. Davis include Monash Medical Centre & National Health and Medical Research Council.
Papers
More filters
Journal ArticleDOI
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
C Davies,Hongchao Pan,Jon Godwin,Richard Gray,Rodrigo Arriagada,Vinod Raina,Mirta Abraham,Victor Hugo Medeiros Alencar,Atef Badran,Xavier Bonfill,Joan Caroline Bradbury,Mike Clarke,Rory Collins,Susan R. Davis,Antonella Delmestri,John F. Forbes,Peiman Haddad,Ming-Feng Hou,Moshe Inbar,Hussein M. Khaled,Joanna Kielanowska,Wing-Hong Kwan,Beela Sarah Mathew,Indraneel Mittra,Bettina Muller,Antonio Nicolucci,Octavio Peralta,Fany Pernas,Lubos Petruzelka,Tadeusz Pienkowski,Ramachandran Radhika,Balakrishnan Rajan,Maryna Rubach,Sera Tort,Gerard Urrútia,Miriam Valentini,Yaochen Wang,Richard Peto +37 more
TL;DR: Treatment allocation seemed to have no effect on breast cancer outcome among 1248 women with ER-negative disease, and an intermediate effect among 4800 women with unknown ER status, and a further reduction in recurrence and mortality, particularly after year 10.
Journal ArticleDOI
Androgen Levels in Adult Females: Changes with Age, Menopause, and Oophorectomy
Sonia Louise Davison,Robin J. Bell,Robin J. Bell,Susan Donath,J G Montalto,Susan R. Davis,Susan R. Davis +6 more
TL;DR: It is reported that serum androgen levels decline steeply in the early reproductive years and do not vary because of natural menopause and that the postmenopausal ovary appears to be an ongoing site of testosterone production.
Journal ArticleDOI
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Richard J. Santen,D. Craig Allred,Stacy P. Ardoin,David F. Archer,Norman F. Boyd,Glenn D. Braunstein,Henry G. Burger,Graham A. Colditz,Susan R. Davis,Marco Gambacciani,Barbara A. Gower,Victor W. Henderson,Wael N. Jarjour,Richard H. Karas,Michael Kleerekoper,Roger A. Lobo,JoAnn E. Manson,Jo Marsden,Kathryn A. Martin,Lisa W. Martin,JoAnn V. Pinkerton,David R. Rubinow,Helena J. Teede,Diane Thiboutot,Wulf H. Utian +24 more
TL;DR: A scholarly review of the published literature on menopausal hormonal therapy (MHT), make scientifically valid assessments of the available data, and grade the level of evidence available for each clinically important endpoint to arrive at major conclusions.
Journal ArticleDOI
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Cynthia A. Stuenkel,Cynthia A. Stuenkel,Susan R. Davis,Anne Gompel,Mary Ann Lumsden,Mary Ann Lumsden,M. Hassan Murad,JoAnn V. Pinkerton,JoAnn V. Pinkerton,Richard J. Santen,Richard J. Santen +10 more
TL;DR: Menopausal hormone therapy (MHT) is the most effective treatment for vasomotor symptoms and other symptoms of the climacteric and benefits may exceed risks for the majority of symptomatic postmenopausal women who are under age 60 or under 10 years since the onset of menopause.
Journal ArticleDOI
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.
TL;DR: It is concluded that in postmenopausal women, treatment with combined estradiol and testosterone implants was more effective in increasing bone mineral density in the hip and lumbar spine thanEstradiol implants alone.